A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
Completed · Phase 4
Conditions studied: Heart Valve Diseases
In brief
Mitral valve regurgitation (leakage of the mitral valve of the heart) is frequent and currently there is no specific medical therapy. Mitral regurgitation is a slowly progressive disease that frequently requires surgical treatment. This randomized clinical trial will use Metoprolol, a common beta-blocker medication, to determine if medical treatment impacts mitral valve disease progression.
Key facts
- Study ID
- NCT00166400
- Run by
- Mayo Clinic
- People needed
- 60
- Starts
- 2004-07-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2008-07-24
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.